BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12772204)

  • 21. Comparison of localized gastric mucosa-associated lymphoid tissue (MALT) lymphoma with and without Helicobacter pylori infection.
    Akamatsu T; Mochizuki T; Okiyama Y; Matsumoto A; Miyabayashi H; Ota H
    Helicobacter; 2006 Apr; 11(2):86-95. PubMed ID: 16579838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synchronous adenocarcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma in a single stomach.
    Lee SY; Kim JJ; Lee JH; Kim YH; Rhee PL; Paik SW; Rhee JC; Ko YH
    Jpn J Clin Oncol; 2005 Oct; 35(10):591-4. PubMed ID: 16254039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined histology and molecular biology for diagnosis of early stage gastric MALT lymphoma.
    Yi ZH; Ouyang Q; Li GD; Chen DY
    Chin J Dig Dis; 2006; 7(1):12-8. PubMed ID: 16412032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastric MALT lymphoma. A clinico-pathological study of 65 cases. Relationship to Helicobacter pylori.
    Ben Rejeb A; Kchir N; Bouali MR; Ebdelli N; Fsili R; Khediri F; Ben Ayedó F; Zitouna MM; Ben Mami N; Kacem M; Filali A; Ben Ammar A
    Tunis Med; 2000; 78(8-9):484-93. PubMed ID: 11190724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of molecular abnormalities in human fibroblastic neoplasms: a model for genotype-phenotype association in soft tissue tumors.
    Hoos A; Lewis JJ; Antonescu CR; Dudas ME; Leon L; Woodruff JM; Brennan MF; Cordon-Cardo C
    Cancer Res; 2001 Apr; 61(7):3171-5. PubMed ID: 11306504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas.
    Kuo SH; Chen LT; Yeh KH; Wu MS; Hsu HC; Yeh PY; Mao TL; Chen CL; Doong SL; Lin JT; Cheng AL
    J Clin Oncol; 2004 Sep; 22(17):3491-7. PubMed ID: 15337797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Our experience in Helicobacter pylori infection and gastric MALToma.
    Losacco T; Cagiano R; Bottalico L; Carlaio RG; Prejbeanu R; Vermesan H; Dragulescu SI; Vermesan D; Motoc A; Santacroce L
    Clin Ter; 2008; 159(4):239-42. PubMed ID: 18776980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between Helicobacter pylori infection and MALT-type lymphoma of the ocular adnexa: clinical and therapeutic implications.
    Ferreri AJ; Ponzoni M; Viale E; Guidoboni M; Conciliis CD; Resti AG; Politi L; Lettini AA; Sacchetti F; Dognini G; Dolcetti R; Doglioni C
    Hematol Oncol; 2006 Mar; 24(1):33-7. PubMed ID: 16385613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in clinicopathological findings, cell kinetics and p53 expression between early gastric cancers with and without Helicobacter pylori infection.
    Mitsuhashi J; Mitomi H; Tanabe S; Koizumi W; Kikuchi S; Ojima T; Okayasu I; Saigenji K
    Hepatogastroenterology; 2004; 51(60):1636-40. PubMed ID: 15532794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication.
    Wündisch T; Thiede C; Morgner A; Dempfle A; Günther A; Liu H; Ye H; Du MQ; Kim TD; Bayerdörffer E; Stolte M; Neubauer A
    J Clin Oncol; 2005 Nov; 23(31):8018-24. PubMed ID: 16204012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of surgery in the patients with stage I and II primary gastric lymphoma.
    Takahashi I; Maehara Y; Koga T; Sumiyoshi Y; Oshiro T; Baba H; Kohnoe S; Okamura T; Uike N; Matsusaka T; Kume K; Sugimachi K
    Hepatogastroenterology; 2003; 50(51):877-82. PubMed ID: 12828109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term results of stomach-conserving therapy in gastric MALT lymphoma.
    Vrieling C; de Jong D; Boot H; de Boer JP; Wegman F; Aleman BM
    Radiother Oncol; 2008 Jun; 87(3):405-11. PubMed ID: 18343513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr viral infection in extranodal lymphoma of the head and neck: correlation with prognosis and response to treatment.
    Bahnassy AA; Zekri AR; Asaad N; El-Houssini S; Khalid HM; Sedky LM; Mokhtar NM
    Histopathology; 2006 Apr; 48(5):516-28. PubMed ID: 16623777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of caspase recruitment domain (CARD) membrane-associated guanylate kinase 1 (CARMA1) and CARD9 in primary gastric B-cell lymphoma.
    Nakamura S; Nakamura S; Matsumoto T; Yada S; Hirahashi M; Suekane H; Yao T; Goda K; Iida M
    Cancer; 2005 Nov; 104(9):1885-93. PubMed ID: 16177990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orbital rhabdomyosarcoma: relationship between DNA ploidy, p53, bcl-2, MDR-1 and Ki67 (MIB1) expression and clinical behavior.
    Staibano S; Franco R; Tranfa F; Mezza E; Lo Muzio L; Strianese D; Errico ME; Bufo P; Ferrara G; Somma P; Mansueto G; Greco I; Fiorillo A; Bonavolontà G; De Rosa G
    Anticancer Res; 2004; 24(1):249-57. PubMed ID: 15015604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Higher frequency of p53 gene mutations in diffuse large B-cell lymphoma with MALT component.
    Tai YC; Tan JA; Peh SC
    Pathol Int; 2004 Nov; 54(11):811-8. PubMed ID: 15533223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53, bcl-2 and thymidine phosphorylase as predictive markers of chemotherapy in patients with advanced and recurrent gastric cancer.
    Kikuyama S; Inada T; Shimizu K; Miyakita M; Ogata Y
    Anticancer Res; 2001; 21(3C):2149-53. PubMed ID: 11501839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma.
    Braaten KM; Betensky RA; de Leval L; Okada Y; Hochberg FH; Louis DN; Harris NL; Batchelor TT
    Clin Cancer Res; 2003 Mar; 9(3):1063-9. PubMed ID: 12631608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of p53, p21, mdm2, Rb, bax and Ki67 proteins in lymphomas of the mucosa-associated lymphoid (MALT) tissue.
    Stefanaki K; Tzardi M; Kouvidou C; Chaniotis V; Bolioti M; Vlychou M; Zois M; Kakolyris S; Delides G; Rontogianni D; Georgoulias V; Kanavaros P
    Anticancer Res; 1998; 18(4A):2403-8. PubMed ID: 9703886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proliferative status is a risk index for recurrence in primary superficial (pTa/T1) low-grade urothelial bladder carcinoma.
    Su JS; Arima K; Hasegawa M; Franco OE; Yanagawa M; Sugimura Y; Kawamura J
    Hinyokika Kiyo; 2003 Nov; 49(11):649-58. PubMed ID: 14719452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.